Pfizer Inc. (PFE) — Business segments and KPIs
Revenue by business segment and geography for Pfizer Inc., with year-over-year trends.
FY 2025
| Segment | Revenue | % of total |
|---|---|---|
| Revenue by product | ||
| Biopharma Segment | 61.20B | 97.8% |
| Segment Reporting, Reconciling Item, Corporate Nonsegment | 1.38B | 2.2% |
| Revenue by region | ||
| UNITED STATES | 37.08B | 59.2% |
| Developed Rest Of World | 16.19B | 25.9% |
| Emerging Markets | 9.31B | 14.9% |